Human serum albumin is the circulating
protein which is synthesized in liver. It undergoes various
modifications in its properties in type
II diabetic patients. There is alteration in N-terminal which leads
to its reduced binding to other metals
and is known as Ischemia Modified Albumin which can be
measured by the albumin cobalt binding
assay which is based on the fact that IMA has reduced
capacity to bind cobalt as compared to
Albumin. IMA is a proven marker for cardiovascular diseases.
It produces reactive oxygen species and
is also a common risk factor for cardiovascular events.
Measuring its levels in type II Diabetes
Mellitus may help to predict the status of complications
associated with it.
Author
(s) Details
Deepika Dalal
Department of Biochemistry, Pt.
BD Sharma Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India.
Kiran Dahiya
Department of Biochemistry, Pt.
BD Sharma Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India.
Keerti Gupta
Department of Biochemistry, Pt.
BD Sharma Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India.
View
Book :-https://bp.bookpi.org/index.php/bpi/catalog/book/248
No comments:
Post a Comment